We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

105 hedge funds and large institutions have $820M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 37 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,325% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 4

721% more capital invested

Capital invested by funds: $99.9M → $820M (+$720M)

363% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 8

102% more funds holding

Funds holding: 52 → 105 (+53)

62% less call options, than puts

Call options by funds: $661K | Put options by funds: $1.73M

Holders
105
Holders Change
+53
Holders Change %
+101.92%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
57
Increased
37
Reduced
8
Closed
4
Calls
$661K
Puts
$1.73M
Net Calls
-$1.07M
Net Calls Change
-$1.07M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$71.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$62.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$46.6M
4
FCM
Farallon Capital Management
California
+$30.1M
5
CAM
Cormorant Asset Management
Massachusetts
+$21.8M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$21.4M
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$1.82M
3
UOC
UBS O'Connor
Illinois
-$1.51M
4
BFM
Boothbay Fund Management
New York
-$1.4M
5
JP Morgan Chase
JP Morgan Chase
New York
-$644K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$97.7M +$62.7M +2,875,567 +174%
CAM
2
Cormorant Asset Management
Massachusetts
$72.4M +$21.8M +1,000,000 +42%
RCM
3
RA Capital Management
Massachusetts
$71M +$71.7M +3,289,119 New
FCM
4
Farallon Capital Management
California
$63.5M +$30.1M +1,380,000 +88%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$47.9M +$12.9M +591,013 +36%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$46.1M +$46.6M +2,136,363 New
BlackRock
7
BlackRock
New York
$40.3M +$21.7M +996,411 +115%
Vanguard Group
8
Vanguard Group
Pennsylvania
$37.2M +$20.5M +937,998 +119%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$29.7M +$12M +550,000 +67%
PCH
10
Polar Capital Holdings
United Kingdom
$28.2M +$6.66M +305,431 +31%
Viking Global Investors
11
Viking Global Investors
Connecticut
$21.2M +$21.4M +981,328 New
IHAM
12
Integral Health Asset Management
New York
$21.1M +$1.64M +75,000 +8%
Jennison Associates
13
Jennison Associates
New York
$20.4M +$10.1M +461,576 +96%
PHP
14
Parkman Healthcare Partners
Connecticut
$15M +$5.74M +263,252 +61%
State Street
15
State Street
Massachusetts
$14M +$7.63M +350,042 +117%
Pictet Asset Management
16
Pictet Asset Management
Switzerland
$12.5M +$12.6M +576,676 New
Marshall Wace
17
Marshall Wace
United Kingdom
$12.2M +$12.4M +566,498 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$12M +$4.83M +221,422 +66%
Millennium Management
19
Millennium Management
New York
$11.5M +$11.6M +533,035 New
JP Morgan Chase
20
JP Morgan Chase
New York
$10.9M -$644K -29,542 -6%
Goldman Sachs
21
Goldman Sachs
New York
$10.4M +$10.2M +466,110 +3,403%
Lord, Abbett & Co
22
Lord, Abbett & Co
New Jersey
$10.3M +$10.4M +475,179 New
DCM
23
Driehaus Capital Management
Illinois
$8.39M +$8.47M +388,472 New
CIBC Asset Management
24
CIBC Asset Management
Ontario, Canada
$7.39M +$2.83M +129,948 +61%
American Century Companies
25
American Century Companies
Missouri
$6.05M +$6.1M +279,926 New
1
2 3 4 5

LBPH Hedge Fund Activity: Q1 2024 in Review

105 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q1 2024, worth a combined $820M — up 721% from $99.9M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new LBPH positions and 4 closed out — a net gain of 53 holders — while 37 added to existing stakes and 8 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $71.7M. The largest seller was Ikarian Capital, cutting an estimated $21.4M.

  • 105 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q1 2024, up from 52 in Q4 2023.
  • Funds reported $820M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q1 2024, up 721% quarter-over-quarter.
  • 57 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of +53 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q1 2024 was RA Capital Management, an estimated $71.7M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q1 2024 was Ikarian Capital, an estimated $21.4M sold.

Based on aggregated 13F filings for Q1 2024.